×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share
21418 views

 

 

18:00
Introduction
Pr Jean-Marc Classe, Institut de Cancérologie de l’Ouest (ICO), Saint-Herblain
 
18:10
Actualités en hormonothérapie
Dr Thibault de la Motte Rouge, Centre Eugène Marquis, Rennes

18:35 Actualité en thérapies ciblées: l’évolution de la place des traitements néoadjuvants
Dr Dorothée Chocteau, Le Confluent, Institut Catherine de Sienne, Nantes
 
19:00 Actualités en radiothérapie
Dr Augustin Mervoyer, ICO, Saint-Herblain
 
19:25 Actualités en chirurgie
Dr Augustin Reynard, ICO, Angers
 
19:50 Résultats de l'étude RxPONDER chez les patientes HER2-, RH+, avec atteinte ganglionnaire
Dr Dorothée Chocteau, Le Confluent, Institut Catherine de Sienne, Nantes

 
20:10 Clôture de la soirée digitale

 

Shooting date : 2021-02-09
Last update : 2021-06-09

Suggestions

Thursday, December 2nd 2021 from 06pm to 07pm (GMT+1)
Honolulu : Thursday, December 2nd 2021 from 07am to 08am (GMT+1)
San Francisco : Thursday, December 2nd 2021 from 09am to 10am (GMT+1)
New York : Thursday, December 2nd 2021 from 12pm to 01pm (GMT+1)
Buenos Aires : Thursday, December 2nd 2021 from 02pm to 03pm (GMT+1)
London / Dublin : Thursday, December 2nd 2021 from 05pm to 06pm (GMT+1)
Paris / Berlin : Thursday, December 2nd 2021 from 06pm to 07pm (GMT+1)
Istanbul : Thursday, December 2nd 2021 from 07pm to 08pm (GMT+1)
Moscou / Dubaï : Thursday, December 2nd 2021 from 09pm to 10pm (GMT+1)
Bangkok : Friday, December 3rd 2021 from 12am to 01am (GMT+1)
Shanghai : Friday, December 3rd 2021 from 01am to 02am (GMT+1)
Tokyo : Friday, December 3rd 2021 from 02am to 03am (GMT+1)
Sydney : Friday, December 3rd 2021 from 03am to 04am (GMT+1)
Wellington : Friday, December 3rd 2021 from 05am to 06am (GMT+1)

SLNB or TAD after NAC in cN1 / ycN0 patients

Share
Tuesday, December 21st 2021 from 06pm to 07:30pm (GMT+1)
Honolulu : Tuesday, December 21st 2021 from 07am to 08:30am (GMT+1)
San Francisco : Tuesday, December 21st 2021 from 09am to 10:30am (GMT+1)
New York : Tuesday, December 21st 2021 from 12pm to 01:30pm (GMT+1)
Buenos Aires : Tuesday, December 21st 2021 from 02pm to 03:30pm (GMT+1)
London / Dublin : Tuesday, December 21st 2021 from 05pm to 06:30pm (GMT+1)
Paris / Berlin : Tuesday, December 21st 2021 from 06pm to 07:30pm (GMT+1)
Istanbul : Tuesday, December 21st 2021 from 07pm to 08:30pm (GMT+1)
Moscou / Dubaï : Tuesday, December 21st 2021 from 09pm to 10:30pm (GMT+1)
Bangkok : Wednesday, December 22nd 2021 from 12am to 01:30am (GMT+1)
Shanghai : Wednesday, December 22nd 2021 from 01am to 02:30am (GMT+1)
Tokyo : Wednesday, December 22nd 2021 from 02am to 03:30am (GMT+1)
Sydney : Wednesday, December 22nd 2021 from 03am to 04:30am (GMT+1)
Wellington : Wednesday, December 22nd 2021 from 05am to 06:30am (GMT+1)

Indication de chimiothérapie néoadjuvante dans la prise en charge des patientes atteintes d’un c...

Share
Thursday, February 1st 2024 from 06pm to 07:30pm (GMT+1)
Honolulu : Thursday, February 1st 2024 from 07am to 08:30am (GMT+1)
San Francisco : Thursday, February 1st 2024 from 09am to 10:30am (GMT+1)
New York : Thursday, February 1st 2024 from 12pm to 01:30pm (GMT+1)
Buenos Aires : Thursday, February 1st 2024 from 02pm to 03:30pm (GMT+1)
London / Dublin : Thursday, February 1st 2024 from 05pm to 06:30pm (GMT+1)
Paris / Berlin : Thursday, February 1st 2024 from 06pm to 07:30pm (GMT+1)
Istanbul : Thursday, February 1st 2024 from 07pm to 08:30pm (GMT+1)
Moscou / Dubaï : Thursday, February 1st 2024 from 09pm to 10:30pm (GMT+1)
Bangkok : Friday, February 2nd 2024 from 12am to 01:30am (GMT+1)
Shanghai : Friday, February 2nd 2024 from 01am to 02:30am (GMT+1)
Tokyo : Friday, February 2nd 2024 from 02am to 03:30am (GMT+1)
Sydney : Friday, February 2nd 2024 from 03am to 04:30am (GMT+1)
Wellington : Friday, February 2nd 2024 from 05am to 06:30am (GMT+1)

Prise en charge du cancer du sein métastatique HER2-faible

Cycle d'enseignement - Le cancer du sein

Share
Thursday, January 18th 2024 from 06pm to 07:30pm (GMT+1)
Honolulu : Thursday, January 18th 2024 from 07am to 08:30am (GMT+1)
San Francisco : Thursday, January 18th 2024 from 09am to 10:30am (GMT+1)
New York : Thursday, January 18th 2024 from 12pm to 01:30pm (GMT+1)
Buenos Aires : Thursday, January 18th 2024 from 02pm to 03:30pm (GMT+1)
London / Dublin : Thursday, January 18th 2024 from 05pm to 06:30pm (GMT+1)
Paris / Berlin : Thursday, January 18th 2024 from 06pm to 07:30pm (GMT+1)
Istanbul : Thursday, January 18th 2024 from 07pm to 08:30pm (GMT+1)
Moscou / Dubaï : Thursday, January 18th 2024 from 09pm to 10:30pm (GMT+1)
Bangkok : Friday, January 19th 2024 from 12am to 01:30am (GMT+1)
Shanghai : Friday, January 19th 2024 from 01am to 02:30am (GMT+1)
Tokyo : Friday, January 19th 2024 from 02am to 03:30am (GMT+1)
Sydney : Friday, January 19th 2024 from 03am to 04:30am (GMT+1)
Wellington : Friday, January 19th 2024 from 05am to 06:30am (GMT+1)

Cancer du sein triple négatif métastatique

Cycle d'enseignement - Le cancer du sein

Share
Scroll Up